Literature DB >> 2368878

Selective shunts: the Johannesburg experience.

J A Myburgh1.   

Abstract

My personal 15-year experience with 141 selective shunts (127 elective, 14 emergency) for portal hypertension is reported. Alcoholic cirrhosis comprised 54% of elective operations, and of the nonalcoholic patients, 22% were cirrhotic and 24% were noncirrhotic. Adequate and, if necessary, prolonged (mean 6 weeks) in-hospital preparation resulted in Hospital mortality and long-term actuarial survival were better in nonalcoholics compared with alcoholics, but there was no significant difference between cirrhotic nonalcoholics and alcoholics. Variceal rebleeding was rare (4% of Warren procedures) and, when present, was usually related to shunt failure. Gastric fundal variceal rebleeding did not occur in 44 patients undergoing splenopancreatic disconnection. Postoperative encephalopathy occurred in 13% of patients; however, it did not occur at all in noncirrhotic patients. Prograde portal venous perfusion was preserved in 77% of patients. Fifteen alternate selective operations to the Warren shunt were performed, usually because of antecedent splenectomy. Shunt failure and variceal rebleeding occurred more frequently with these more vulnerable shunts, but 66% had a satisfactory outcome. Selective shunts have produced highly satisfactory results in appropriately selected patients.

Entities:  

Mesh:

Year:  1990        PMID: 2368878     DOI: 10.1016/s0002-9610(05)80871-2

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  2 in total

1.  LncRNA-BLACAT1 Facilitates Proliferation, Migration and Aerobic Glycolysis of Pancreatic Cancer Cells by Repressing CDKN1C via EZH2-Induced H3K27me3.

Authors:  Xin Zhou; Wei Gao; Huanhuan Hua; Zhimin Ji
Journal:  Front Oncol       Date:  2020-09-23       Impact factor: 6.244

2.  Selective shunt in the management of variceal bleeding in the era of liver transplantation.

Authors:  J M Henderson; G T Gilmore; M A Hooks; J R Galloway; T F Dodson; M M Hood; M H Kutner; T D Boyer
Journal:  Ann Surg       Date:  1992-09       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.